Food-tech disruptor prepares to vastly scale dairy-identical, non-animal milk protein production in a pioneering sustainable industrial park in Denmark
In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
Ind-Ra maintains a neutral outlook for healthcare in FY23
Air purification system achieves Intertek zero ozone certification
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
In the interim, Deepak Khanna will lead Human Health International.
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
Subscribe To Our Newsletter & Stay Updated
